InvestorsHub Logo
Followers 19
Posts 1694
Boards Moderated 0
Alias Born 09/23/2016

Re: None

Tuesday, 02/22/2022 8:24:01 AM

Tuesday, February 22, 2022 8:24:01 AM

Post# of 121
Novavax announced approval in Canada just last week and preorder of 51M doses (possibly 61M) by Australia, and the market treated it like a dry fart! ADG20 is sooo late to the party I'm afraid!


Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates
February 22 2022 - 07:30AM
GlobeNewswire Inc.

Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today outlined strategic initiatives for its ADG20 program, as well as research efforts to address SARS-CoV-2 and other coronaviruses. ADG20 is an investigational monoclonal antibody (mAb) being developed for the prevention and treatment of COVID-19.